Article ID Journal Published Year Pages File Type
3235264 Apollo Medicine 2008 7 Pages PDF
Abstract

Breast cancer is the second leading cause of cancer death in women. There is a need to determine the individual risk of breast cancer accurately in order to reduce the breast cancer specific mortality and morbidity.Tamoxifen and prophylactic mastectomy are known to decrease the incidence of breast high risk women. This article tries to evaluate the risk/benefit ratio of the available modality reduction.

Related Topics
Health Sciences Medicine and Dentistry Emergency Medicine